<DOC>
	<DOCNO>NCT02049112</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy , safety acceptability new oral salivary equivalent relief sign symptom relate mouth dryness compare two distinct moisturize currently market oral spray ( Aequasyal® &amp; Biotene® ) patient xerostomia due chronic hyposalivation .</brief_summary>
	<brief_title>A New Oral salIvary equivAlent Compared Two moisturizinG Mouth sprAys Patients With xeRostomiA : NIAGARA Study</brief_title>
	<detailed_description>National , multicentre , randomise , active control , crossover , open-label study use 3-latin-square design . 200 evaluable patient recruit</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>Patients : Aged 18 year , Clinical diagnosis xerostomia severe reduction salivation , detect patient 's answer specific question measure saliva volume screen visit ( test saliva weight absorb ≤ 0.1g/min ) Any medical condition treatment lead severe reduction salivation relate either : Head neck radiation therapy cancer , GougerotSjögren syndrome Medications know induce xerostomia ( psychotropic drug , antihypertensive drug ) Dehydration , hypothyroidism , Parkinson 's disease and/or diabetes mellitus Female patient must postmenopausal use highly effective method avoidance pregnancy throughout whole study duration , childbearing potential . Able understand comply protocol procedure Willing able give write informed consent Affiliated French National Health Insurance Program Known hypersensitivity one study product one component Any plan change dose know medication induce mouth dryness Concomitant treatment xerostomia symptom without scheduled 3 7day withdrawal window Oral candidiasis diagnose microbiological test obtain unstimulated whole saliva sample 3week period disease release Oral ulceration Alcohol ( &gt; 2 glass wine/day ) , smoke ( &gt; 10 cigarettes/day ) , caffeine and/or theine intake ( &gt; 4 cups/day ) Patients unable fill questionnaire comply study protocol Dental infection Patients participate another clinical trial time study entry within 30 day prior study enrolment Lifethreatening condition time study Pregnant lactate woman woman childbearing potential refusing use adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Cross-over</keyword>
	<keyword>Salivary equivalent</keyword>
	<keyword>Dry mouth</keyword>
	<keyword>Medical device</keyword>
</DOC>